Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus. - Wikidata - awgldk - TriplyDB

Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.

Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.

http://www.wikidata.org/entity/Q53902963

about

Combination treatment in autoimmune diseases: systemic lupus erythematosus.The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.Challenges in bringing the bench to bedside in drug development for SLE.Emergence of targeted immune therapies for systemic lupus.Basic immunosuppressive drugs outside solid organ transplantation.Kozhikode criteria for diagnosing systemic lupus erythematosus as a hematological disorder.Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: a systematic review.Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.Pharmacokinetic modeling of therapies for systemic lupus erythematosus.The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells.Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice

P2860

Q34309764-41FC2C8C-B126-4224-A933-AE36ADBCB6FD Q35897121-DC4AF37C-AB77-4D7B-AB1B-DB4DF3775AF5 Q35968394-28069F0A-AE99-412E-AE00-50783D5AF883 Q36066014-B90929BF-AA5D-401C-9457-4645799C265D Q36407314-9022CD67-DB79-4CEB-973A-E2C43430F9A2 Q36688076-6B8E764C-0006-40BF-87B8-6ACBD6C360EC Q38101015-89A2E60B-7484-495F-A8CA-47FF3C0B68A2 Q38372154-16E514F8-F84C-4C91-9B85-16B3007ECE79 Q38542910-25CA9570-44A3-42FB-8BBC-76B748C232BA Q38925320-69466FC5-0935-44EE-B4AF-9FAD0B8AC650 Q44517198-3814645C-CA9C-4EBC-A6AC-BBB32437DDF3 Q58204835-B4203C03-5210-4FDF-BA02-8AF77EE6E2E1

P2860

Cyclosporine-A plus steroids versus steroids alone in the 12-month treatment of systemic lupus erythematosus.

http://www.wikidata.org/entity/Q53902963

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh

2000年學術文章

@zh-hant

name

Cyclosporine-A plus steroids v ...... systemic lupus erythematosus.

@en

Cyclosporine-A plus steroids v ...... systemic lupus erythematosus.

@nl

type

label

Cyclosporine-A plus steroids v ...... systemic lupus erythematosus.

@en

Cyclosporine-A plus steroids v ...... systemic lupus erythematosus.

@nl

prefLabel

Cyclosporine-A plus steroids v ...... systemic lupus erythematosus.

@en

Cyclosporine-A plus steroids v ...... systemic lupus erythematosus.

@nl

P1433

Q53902963-5753594B-55F2-46C1-8ACA-56305F1C7E38

P1476

Q53902963-082DF10C-5E2C-4409-8059-6852EE30F11B

P2093

Q53902963-3D256361-0FC6-48B4-B460-2DEF88D07AEA

Q53902963-46622150-5668-4975-A8AE-550550F09B2A

Q53902963-4F564BFC-78D3-439A-A1A0-44FC9F6460F1

Q53902963-C459DF56-3932-4256-9A6A-B0CA315AAE3D

P2860

Q53902963-0CD55A8A-170C-4DC3-9C33-45D6E4165578

Q53902963-3789FCA8-CF55-47EB-A930-64549F135403

Q53902963-8A7CF180-9276-41B3-AA74-325EABF24109

Q53902963-98E2D10B-45A2-4D58-9494-522019B2430D

Q53902963-AC7414E7-676C-4864-92EC-BC78A0BC7A36

Q53902963-CAD805F9-752A-4374-86CA-B1DA8E69152C

Q53902963-D05DF36D-FEAA-40A5-9F57-BD1A95A1145D

Q53902963-E0F070A9-DF83-4584-A07B-F29A29B5C1E8

Q53902963-E4D76F99-9AFA-4BF0-8152-EE5C55C18816

Q53902963-F7AB6620-051C-44C3-9201-BC0C4A2BCED1

P2888

Q53902963-39A56DFF-40D2-4DDE-9640-CEE019E16AF9

P304

Q53902963-4B126BAA-C9FB-4EA9-8680-BBFD5BE82F16

P31

Q53902963-15914A7C-F966-4443-A5A1-67A7A23B5256

P356

Q53902963-C0A23937-B971-4225-8065-95105C0AED79

P433

Q53902963-637CB7A3-574C-4E9D-AD62-03681915AC27

P478

Q53902963-A5964C62-CF49-40D1-B296-8842F9678A4D

P50

Q53902963-5ED4E4DB-62F6-4AD6-8BAE-5E3855B885EB

Q53902963-E00AC217-58DC-4D61-8A1D-6895DA51D008

P577

Q53902963-F287AE7B-84B6-438C-A4BF-38A1B60CBA18

P698

Q53902963-EBA9082A-A8FA-49B7-8B8D-458E35371B19

P356

P1433

International Journal of Clinical and Laboratory Research

P1476

Cyclosporine-A plus steroids v ...... f systemic lupus erythematosus

@en

P2093

Bartoli E

http://www.w3.org/2001/XMLSchema#string

Casatta L

http://www.w3.org/2001/XMLSchema#string

Dammacco F

http://www.w3.org/2001/XMLSchema#string

Della Casa Alberighi O

http://www.w3.org/2001/XMLSchema#string

P2860

The 1982 revised criteria for the classification of systemic lupus erythematosus

Prediction of creatinine clearance from serum creatinine

Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study.

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

Systemic lupus erythematosus. Treatment-related complications superimposed on chronic disease.

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Ciclosporin in the treatment of lupus nephritis.

Effects of cyclosporine in severe systemic lupus erythematosus.

Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

P2888

P304

67-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S005990070017

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Gianfranco Ferraccioli

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11043499

http://www.w3.org/2001/XMLSchema#string